Zobrazeno 1 - 7
of 7
pro vyhledávání: '"G L Parenteau"'
Autor:
S A Tinubu, J Hakimi, J A Kondas, P Bailon, P C Familletti, C Spence, M D Crittenden, G L Parenteau, F M Dirbas, M Tsudo
Publikováno v:
The Journal of Immunology. 153:4330-4338
IL-2Rs are expressed by T cells activated in response to foreign histocompatibility Ags but not by normal cells. This difference in IL-2R expression is exploited by blockade of IL-2Rs to achieve immunosuppression. High affinity IL-2Rs involve three s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30c2b2be17ec54af67a10f8c171bffa7
https://doi.org/10.4049/jimmunol.153.9.4330
https://doi.org/10.4049/jimmunol.153.9.4330
Autor:
J M Poston, G L Parenteau
Publikováno v:
Archives of Biochemistry and Biophysics. 295:35-41
Isolated working rat hearts perfused with Krebs-Hensleit buffer were arrested and made ischemic. After 22 min, the hearts were reperfused with buffer, yielding restoration of function. Nucleotide levels rose and fell in the cardiac tissue as ischemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1ac1f3cff46f61e3aeb7bb2f68f29d6
https://doi.org/10.1016/0003-9861(92)90484-e
https://doi.org/10.1016/0003-9861(92)90484-e
Autor:
Iglesias González, Ana Belén, Jakobsson, Jon E. T., Vieillard, Jennifer, Lagerström, Malin C., Kullander, Klas, Boije, Henrik
Publikováno v:
Frontiers in Cellular Neuroscience; 12/23/2021, Vol. 15, p1-19, 19p
Autor:
STADTMAN, EARL R., LEVINE, RODNEY L.
Publikováno v:
Annals of the New York Academy of Sciences; 2000, Vol. 899 Issue 1, p191-208, 18p
Publikováno v:
American Journal of Physiology: Heart & Circulatory Physiology; Mar1995, Vol. 268 Issue 3, pH1165-H1173, 9p
Autor:
Stadtman, Earl R., Berlett, Barbara S.
Publikováno v:
Drug Metabolism Reviews; 1998, Vol. 30 Issue 2, p225-243, 19p
Autor:
Carleton T. Garrett, Stewart Sell
In Cellular Cancer Markers leading pathologists and physicians review today's most promising cellular cancer markers, an important emerging class of prognostic markers that can be used in the clinical evaluation of cancer patients. The markers review
